Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World ...

Bayer ForwardFarming in India promotes sustainable rice cultivation, regenerative agriculture, and innovative farming ...

BAYRY's NSCLC drug BAY 2927088 shows an encouraging safety profile in the expansion part of the ongoing study. The company ...

For the first time, global life sciences major Bayer has launched the concept of ‘Forward Farms’ in India to promote ...

Bayer South Asia President highlights the need for modernization in Indian agriculture, emphasizing the role of herbicides, DSR adoption, and biostimulants in achieving sustainable growth.

Bayer has launched its 'Bayer ForwardFarming' initiative in India, focusing on sustainable rice cultivation and regenerative ...

"Many initiatives we hear from the new government are clearly focused on modernizing Indian agriculture," he said.

Within the new Golden Ticket program of Bayer, Genvor to receive fully funded access to lab space and equipment in California ...

Data from Phase I/II SOHO-01 trial presented at 2024 World Conference on Lung Cancer Investigational BAY 2927088 is an oral, small molecule, tyrosine kinase inhibitor as a potential new targeted ...

Bayer initiates patient enrolment in phase III SOHO-02 trial of BAY 2927088 in non-small cell lung cancer: Berlin Saturday, August 31, 2024, 10:00 Hrs [IST] Bayer announced that t ...

Bayer will present new oncology data, including a late-breaking, comprehensive analysis from the Phase III ARANOTE trial ...